MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BBOT made $53,635K in revenue. -$44,757K in net income. Net profit margin of -83.45%.

Income Overview

Revenue
$53,635K
Net Income
-$44,757K
Net Profit Margin
-83.45%
EPS
-$1.03
Unit: Thousand (K) dollars
Revenue Breakdown
    • Research and development
    • General and administrative
    • Interest income
    • Income from transition services ...

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
Research and development
35,052
General and administrative
14,129
Total operating expenses
49,181
Loss from operations
-49,181
Interest income
3,444
Income from transition services agreements
1,010
Change in fair value of participation right liability
0
Other income (expense)
-30
Total other income (expense), net
4,424
Net loss
-44,757
Basic net income per ordinary share
-1.03
Diluted net income per ordinary share
-1.03
Weighted-average shares outstanding basic
43,491,085
Weighted-average shares outstanding diluted
43,491,085
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Income from transitionservices agreements$1,010K Interest income$3,444K Net loss-$44,757K Total other income(expense), net$4,424K Other income(expense)-$30K Loss from operations-$49,181K Total operatingexpenses$49,181K General andadministrative$14,129K Research and development$35,052K

BridgeBio Oncology Therapeutics, Inc. (BBOT)

BridgeBio Oncology Therapeutics, Inc. (BBOT)